Can a new graft keep dialysis access working longer?
NCT ID NCT05846581
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study follows people with end-stage kidney disease who need a vascular graft for hemodialysis. The GORE ACUSEAL graft is placed to create a reliable access point for dialysis. Researchers will track how often the graft becomes infected and how long it stays functional, aiming to see if it holds up well over 24 months. The goal is to gather real-world evidence on the graft's safety and performance in routine clinical care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- GORE® ACUSEAL Vascular Graft (a medical device used to create vascular access for hemodialysis)
- What this could lead to
- If successful, this could confirm that the GORE ACUSEAL graft is a safe and reliable option for long-term dialysis access, potentially improving outcomes for people with kidney failure.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be influenced by patient differences. The graft may still carry risks like infection or blockage, and the study's findings depend on real-world follow-up.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ASST-Settelaghi Ospedale di Circolo e Fondazione Macchi
RECRUITINGVarese, 21100, Italy
-
Ev. DiakonissenKrankenhaus Leipzigemeinnützige
RECRUITINGLeipzig, 04177, Germany
-
Evangelisches Klinikum Bethel (EvKB)
RECRUITINGBielefeld, 33611, Germany
-
North Bristol NHS Trust Southmead Hospital
TERMINATEDBristol, England, BS10 5NB, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a new drug combo shield young hearts from transplant complications?
- A common supplement may shield bones in kidney disease — a trial puts it to the test